Alpha Paradigm Partners, LLC Mckesson Corp Transaction History

Alpha Paradigm Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$300.57 - $336.42 $145,475 - $162,827	-484 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$244.61 - $310.48 $466,471 - $592,085	-1,907 Reduced 79.76%	484 $148 Million
Q4 2021 Feb 14, 2022	BUY	$198.21 - $248.9 $228,932 - $287,479	1,155 Added 93.45%	2,391 $594 Million
Q3 2021 Nov 15, 2021	SELL	$188.42 - $208.66 $470,107 - $520,606	-2,495 Reduced 66.87%	1,236 $246 Million
Q2 2021 Aug 13, 2021	BUY	$184.89 - $202.68 $429,869 - $471,231	2,325 Added 165.36%	3,731 $714 Million
Q1 2021 May 14, 2021	SELL	$169.52 - $196.53 $505,847 - $586,445	-2,984 Reduced 67.97%	1,406 $274,000
Q4 2020 Feb 12, 2021	BUY	$143.79 - $183.66 $631,238 - $806,267	4,390 New	4,390 $764,000

1,713

112M

871K

900K

Ticker MCK
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 143,730,000
Market Cap $75.6B
Description
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...

Get notified when there are updates to the investment portfolio of Alpha Paradigm Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Paradigm Partners, LLC with notifications on news.